Evidence map›Paper›PMID 26090662›Full record

ArticlePloS one2015

HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.

Nawal Ben Haij, Rémi Planès, Kaoutar Leghmari, Manutea Serrero, Pierre Delobel, Jacques Izopet, Lbachir BenMohamed, Elmostafa Bahraoui

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Mouse Models of HIV-Associated Atherosclerosis.International journal of molecular sciences · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. TLR4 signalling: the key to controlling EV71 replication and inflammatory response.Frontiers in cellular and infection microbiology · 2024
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nawal Ben HaijINSERM, U1043, Toulouse, France, CNRS, U5282, Toulouse, France; Université Paul Sabatier Toulouse, Toulouse, France; Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France.
Rémi PlanèsINSERM, U1043, Toulouse, France, CNRS, U5282, Toulouse, France; Université Paul Sabatier Toulouse, Toulouse, France; Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France.
Kaoutar LeghmariINSERM, U1043, Toulouse, France, CNRS, U5282, Toulouse, France; Université Paul Sabatier Toulouse, Toulouse, France; Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France.
Manutea SerreroINSERM, U1043, Toulouse, France, CNRS, U5282, Toulouse, France; Université Paul Sabatier Toulouse, Toulouse, France; Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France.
Pierre DelobelINSERM, U1043, Toulouse, France, CNRS, U5282, Toulouse, France; Université Paul Sabatier Toulouse, Toulouse, France; Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France.
Jacques IzopetINSERM, U1043, Toulouse, France, CNRS, U5282, Toulouse, France; Université Paul Sabatier Toulouse, Toulouse, France; Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France.
Lbachir BenMohamedLaboratory of Cellular and Molecular Immunology, Gavin Herbert Eye Institute, University of California Irvine, School of Medicine, Irvine, CA, 92697, United States of America; Institute for Immunology, Irvine, CA, 92697, United States of America; Department of Molecular Biology & Biochemistry, University of California Irvine, School of Medicine, Irvine, CA, 92697, United States of America.
Elmostafa BahraouiINSERM, U1043, Toulouse, France, CNRS, U5282, Toulouse, France; Université Paul Sabatier Toulouse, Toulouse, France; Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France.

Funding

Therapeutic Ocular HSV Vaccine in HLA Transgenic RabbitsR01EY019896 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2010 to 2025
$5.1M
Ocular Mucsoal Immunity Induced by HSV-1 LipopeptidesR01EY014900 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2003 to 2014
$3.1M
NEI NIH HHS EY 019896NEI NIH HHS EY14900NEI NIH HHS R01 EY014900NEI NIH HHS R01 EY019896
6 · The paper itself

Abstract

We recently reported that the human immunodeficiency virus type-1 (HIV-1) Tat protein induced the expression of programmed death ligand-1 (PD-L1) on dendritic cells (DCs) through a TLR4 pathway. However, the underlying mechanisms by which HIV-1 Tat protein induces the abnormal hyper-activation of the immune system seen in HIV-1 infected patients remain to be fully elucidated. In the present study, we report that HIV-1 Tat protein induced the production of significant amounts of the pro-inflammatory IL-6 and IL-8 cytokines by DCs and monocytes from both healthy and HIV-1 infected patients. Such production was abrogated in the presence of anti-TLR4 blocking antibodies or soluble recombinant TLR4-MD2 as a decoy receptor, suggesting TLR4 was recruited by Tat protein. Tat-induced murine IL-6 and CXCL1/KC a functional homologue of human IL-8 was abolished in peritoneal macrophages derived from TLR4 KO but not from Wt mice, confirming the involvement of the TLR4 pathway. Furthermore, the recruitment of TLR4-MD2-CD14 complex by Tat protein was demonstrated by the activation of TLR4 downstream pathways including NF-κB and SOCS-1 and by down-modulation of cell surface TLR4 by endocytosis in dynamin and lipid-raft-dependent manners. Collectively, these findings demonstrate, for the first time, that HIV-1 Tat interacts with TLR4-MD2-CD14 complex and activates the NF-κB pathway, leading to overproduction of IL-6 and IL-8 pro-inflammatory cytokines by myeloid cells from both healthy and HIV-1 infected patients. This study reveals a novel mechanism by which HIV-1, via its early expressed Tat protein, hijacks the TLR4 pathway, hence establishing abnormal hyper-activation of the immune system.

Indexed as

AnimalsCell LineCytokinesDendritic CellsDynaminsEndocytosisHIV InfectionsHumansInflammation MediatorsLipopolysaccharide ReceptorsLymphocyte Antigen 96MacrophagesMacrophages, PeritonealMiceMonocytesMultiprotein ComplexesCytokinesDynaminsInflammation MediatorsLipopolysaccharide ReceptorsLymphocyte Antigen 96Multiprotein ComplexesNF-kappa BSOCS1 protein, humanSuppressor of Cytokine Signaling 1 ProteinSuppressor of Cytokine Signaling Proteinstat Gene Products, Human Immunodeficiency VirusToll-Like Receptor 4

Identifiers

PMID26090662
PMCPMC4474861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.